Condition
Glycocalyx
Total Trials
5
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06993740Not ApplicableRecruiting
Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient
NCT06611904Not ApplicableActive Not Recruiting
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
NCT04764266Not ApplicableCompletedPrimary
Glycocalyx During Normothermic Machine Perfusion
NCT04332952CompletedPrimary
Damage and Renal Clearance of Glycocalyx in Cardiac Surgery
NCT02783443Completed
Effect General and Regional Anesthesia on Glycocalyx
Showing all 5 trials